Page last updated: 2024-11-12

lg190178

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID15521397
CHEMBL ID197589
SCHEMBL ID3392118
MeSH IDM0518254

Synonyms (11)

Synonym
gtpl2787
3-[4-[3-[4-(2-hydroxy-3,3-dimethylbutoxy)-3-methylphenyl]pentan-3-yl]-2-methylphenoxy]propane-1,2-diol
lg-190178
CHEMBL197589
SCHEMBL3392118
lg190178
Q27080276
233268-81-0
bdbm50521018
cid 15521397
AKOS040748744
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (4)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Androgen receptorHomo sapiens (human)IC50 (µMol)10.00000.00000.875310.0000AID730427
Androgen receptorMus musculus (house mouse)IC50 (µMol)0.01900.00100.87503.0000AID255943
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Vitamin D3 receptorHomo sapiens (human)EC50 (µMol)0.04000.00000.14232.1400AID730430
Vitamin D3 receptorMus musculus (house mouse)EC50 (µMol)0.00770.00770.40190.9000AID1585872
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Vitamin D3 receptorHomo sapiens (human)ED500.04400.00050.14280.4100AID255706
Vitamin D3 receptorHomo sapiens (human)PC500.14000.14002.37004.6000AID730431
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (80)

Processvia Protein(s)Taxonomy
negative regulation of transcription by RNA polymerase IIAndrogen receptorHomo sapiens (human)
MAPK cascadeAndrogen receptorHomo sapiens (human)
in utero embryonic developmentAndrogen receptorHomo sapiens (human)
regulation of systemic arterial blood pressureAndrogen receptorHomo sapiens (human)
epithelial cell morphogenesisAndrogen receptorHomo sapiens (human)
transcription by RNA polymerase IIAndrogen receptorHomo sapiens (human)
signal transductionAndrogen receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayAndrogen receptorHomo sapiens (human)
cell-cell signalingAndrogen receptorHomo sapiens (human)
spermatogenesisAndrogen receptorHomo sapiens (human)
single fertilizationAndrogen receptorHomo sapiens (human)
positive regulation of cell population proliferationAndrogen receptorHomo sapiens (human)
negative regulation of cell population proliferationAndrogen receptorHomo sapiens (human)
positive regulation of gene expressionAndrogen receptorHomo sapiens (human)
male somatic sex determinationAndrogen receptorHomo sapiens (human)
intracellular estrogen receptor signaling pathwayAndrogen receptorHomo sapiens (human)
androgen receptor signaling pathwayAndrogen receptorHomo sapiens (human)
intracellular receptor signaling pathwayAndrogen receptorHomo sapiens (human)
positive regulation of intracellular estrogen receptor signaling pathwayAndrogen receptorHomo sapiens (human)
Leydig cell differentiationAndrogen receptorHomo sapiens (human)
multicellular organism growthAndrogen receptorHomo sapiens (human)
positive regulation of phosphorylationAndrogen receptorHomo sapiens (human)
positive regulation of MAPK cascadeAndrogen receptorHomo sapiens (human)
positive regulation of insulin-like growth factor receptor signaling pathwayAndrogen receptorHomo sapiens (human)
positive regulation of cell differentiationAndrogen receptorHomo sapiens (human)
negative regulation of integrin biosynthetic processAndrogen receptorHomo sapiens (human)
positive regulation of integrin biosynthetic processAndrogen receptorHomo sapiens (human)
positive regulation of DNA-templated transcriptionAndrogen receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIAndrogen receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIIAndrogen receptorHomo sapiens (human)
insulin-like growth factor receptor signaling pathwayAndrogen receptorHomo sapiens (human)
regulation of developmental growthAndrogen receptorHomo sapiens (human)
animal organ formationAndrogen receptorHomo sapiens (human)
male genitalia morphogenesisAndrogen receptorHomo sapiens (human)
epithelial cell proliferationAndrogen receptorHomo sapiens (human)
negative regulation of epithelial cell proliferationAndrogen receptorHomo sapiens (human)
positive regulation of NF-kappaB transcription factor activityAndrogen receptorHomo sapiens (human)
activation of prostate induction by androgen receptor signaling pathwayAndrogen receptorHomo sapiens (human)
morphogenesis of an epithelial foldAndrogen receptorHomo sapiens (human)
lateral sprouting involved in mammary gland duct morphogenesisAndrogen receptorHomo sapiens (human)
prostate gland growthAndrogen receptorHomo sapiens (human)
prostate gland epithelium morphogenesisAndrogen receptorHomo sapiens (human)
epithelial cell differentiation involved in prostate gland developmentAndrogen receptorHomo sapiens (human)
tertiary branching involved in mammary gland duct morphogenesisAndrogen receptorHomo sapiens (human)
mammary gland alveolus developmentAndrogen receptorHomo sapiens (human)
positive regulation of epithelial cell proliferation involved in prostate gland developmentAndrogen receptorHomo sapiens (human)
cellular response to steroid hormone stimulusAndrogen receptorHomo sapiens (human)
cellular response to estrogen stimulusAndrogen receptorHomo sapiens (human)
cellular response to testosterone stimulusAndrogen receptorHomo sapiens (human)
seminiferous tubule developmentAndrogen receptorHomo sapiens (human)
non-membrane-bounded organelle assemblyAndrogen receptorHomo sapiens (human)
positive regulation of miRNA transcriptionAndrogen receptorHomo sapiens (human)
regulation of protein localization to plasma membraneAndrogen receptorHomo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathwayAndrogen receptorHomo sapiens (human)
male gonad developmentAndrogen receptorHomo sapiens (human)
intracellular steroid hormone receptor signaling pathwayAndrogen receptorHomo sapiens (human)
negative regulation of DNA-templated transcriptionVitamin D3 receptorHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIVitamin D3 receptorHomo sapiens (human)
cell morphogenesisVitamin D3 receptorHomo sapiens (human)
skeletal system developmentVitamin D3 receptorHomo sapiens (human)
calcium ion transportVitamin D3 receptorHomo sapiens (human)
intracellular calcium ion homeostasisVitamin D3 receptorHomo sapiens (human)
lactationVitamin D3 receptorHomo sapiens (human)
negative regulation of cell population proliferationVitamin D3 receptorHomo sapiens (human)
positive regulation of gene expressionVitamin D3 receptorHomo sapiens (human)
negative regulation of keratinocyte proliferationVitamin D3 receptorHomo sapiens (human)
positive regulation of vitamin D 24-hydroxylase activityVitamin D3 receptorHomo sapiens (human)
positive regulation of bone mineralizationVitamin D3 receptorHomo sapiens (human)
phosphate ion transmembrane transportVitamin D3 receptorHomo sapiens (human)
bile acid signaling pathwayVitamin D3 receptorHomo sapiens (human)
mRNA transcription by RNA polymerase IIVitamin D3 receptorHomo sapiens (human)
positive regulation of keratinocyte differentiationVitamin D3 receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIVitamin D3 receptorHomo sapiens (human)
decidualizationVitamin D3 receptorHomo sapiens (human)
intestinal absorptionVitamin D3 receptorHomo sapiens (human)
apoptotic process involved in mammary gland involutionVitamin D3 receptorHomo sapiens (human)
positive regulation of apoptotic process involved in mammary gland involutionVitamin D3 receptorHomo sapiens (human)
regulation of calcidiol 1-monooxygenase activityVitamin D3 receptorHomo sapiens (human)
mammary gland branching involved in pregnancyVitamin D3 receptorHomo sapiens (human)
vitamin D receptor signaling pathwayVitamin D3 receptorHomo sapiens (human)
positive regulation of vitamin D receptor signaling pathwayVitamin D3 receptorHomo sapiens (human)
response to bile acidVitamin D3 receptorHomo sapiens (human)
multicellular organism developmentVitamin D3 receptorHomo sapiens (human)
cell differentiationVitamin D3 receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (29)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingAndrogen receptorHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingAndrogen receptorHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificAndrogen receptorHomo sapiens (human)
RNA polymerase II general transcription initiation factor bindingAndrogen receptorHomo sapiens (human)
transcription coactivator bindingAndrogen receptorHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificAndrogen receptorHomo sapiens (human)
chromatin bindingAndrogen receptorHomo sapiens (human)
DNA-binding transcription factor activityAndrogen receptorHomo sapiens (human)
nuclear receptor activityAndrogen receptorHomo sapiens (human)
G protein-coupled receptor activityAndrogen receptorHomo sapiens (human)
signaling receptor bindingAndrogen receptorHomo sapiens (human)
steroid bindingAndrogen receptorHomo sapiens (human)
androgen bindingAndrogen receptorHomo sapiens (human)
protein bindingAndrogen receptorHomo sapiens (human)
beta-catenin bindingAndrogen receptorHomo sapiens (human)
zinc ion bindingAndrogen receptorHomo sapiens (human)
enzyme bindingAndrogen receptorHomo sapiens (human)
ATPase bindingAndrogen receptorHomo sapiens (human)
molecular adaptor activityAndrogen receptorHomo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingAndrogen receptorHomo sapiens (human)
POU domain bindingAndrogen receptorHomo sapiens (human)
molecular condensate scaffold activityAndrogen receptorHomo sapiens (human)
estrogen response element bindingAndrogen receptorHomo sapiens (human)
DNA-binding transcription factor activityVitamin D3 receptorHomo sapiens (human)
vitamin D response element bindingVitamin D3 receptorHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificVitamin D3 receptorHomo sapiens (human)
DNA bindingVitamin D3 receptorHomo sapiens (human)
nuclear receptor activityVitamin D3 receptorHomo sapiens (human)
protein bindingVitamin D3 receptorHomo sapiens (human)
zinc ion bindingVitamin D3 receptorHomo sapiens (human)
bile acid nuclear receptor activityVitamin D3 receptorHomo sapiens (human)
nuclear retinoid X receptor bindingVitamin D3 receptorHomo sapiens (human)
calcitriol bindingVitamin D3 receptorHomo sapiens (human)
lithocholic acid bindingVitamin D3 receptorHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingVitamin D3 receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (10)

Processvia Protein(s)Taxonomy
plasma membraneAndrogen receptorHomo sapiens (human)
nucleusAndrogen receptorHomo sapiens (human)
nucleoplasmAndrogen receptorHomo sapiens (human)
cytoplasmAndrogen receptorHomo sapiens (human)
cytosolAndrogen receptorHomo sapiens (human)
nuclear speckAndrogen receptorHomo sapiens (human)
chromatinAndrogen receptorHomo sapiens (human)
protein-containing complexAndrogen receptorHomo sapiens (human)
nucleusAndrogen receptorHomo sapiens (human)
nucleusVitamin D3 receptorHomo sapiens (human)
nucleusVitamin D3 receptorHomo sapiens (human)
nucleoplasmVitamin D3 receptorHomo sapiens (human)
cytosolVitamin D3 receptorHomo sapiens (human)
RNA polymerase II transcription regulator complexVitamin D3 receptorHomo sapiens (human)
chromatinVitamin D3 receptorHomo sapiens (human)
receptor complexVitamin D3 receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (33)

Assay IDTitleYearJournalArticle
AID1585872Activation of VDR in mouse ASZ001 cells assessed as change in Cyp24A1 mRNA expression after 48 hrs by q-PCR analysis2019European journal of medicinal chemistry, Jan-15, Volume: 162Synthesis and evaluation of third generation vitamin D3 analogues as inhibitors of Hedgehog signaling.
AID1585888Inhibition of Hedgehog signaling pathway in VDR-deficient mouse C3H10T1/2 cells assessed as reduction in oxysterol-induced Gli1 mRNA expression after 24 hrs by q-PCR analysis2019European journal of medicinal chemistry, Jan-15, Volume: 162Synthesis and evaluation of third generation vitamin D3 analogues as inhibitors of Hedgehog signaling.
AID1353236Antifibrotic activity against TGFbeta1 stimulated rat LTC-14 cells assessed as inhibition of collagen 1 level at 500 nM after 24 hrs by Western blot2018European journal of medicinal chemistry, Feb-25, Volume: 146Design, synthesis and biological evaluation of non-secosteriodal vitamin D receptor ligand bearing double side chain for the treatment of chronic pancreatitis.
AID254447Binding affinity to androgen receptor by incubation with GST-hARLBD and [3H]testosterone; ND = not detected2005Bioorganic & medicinal chemistry letters, Oct-01, Volume: 15, Issue:19
Ligands with dual vitamin D3-agonistic and androgen-antagonistic activities.
AID730427Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of transcriptional activity by luciferase and beta-galactosidase reporter gene assay2013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
Development of silicon-containing bis-phenol derivatives as androgen receptor antagonists: selectivity switching by C/Si exchange.
AID730430Agonist activity at VDR (unknown origin) by reporter gene assay2013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
Development of silicon-containing bis-phenol derivatives as androgen receptor antagonists: selectivity switching by C/Si exchange.
AID721295Agonist activity at VDR in human MG-63 cells assessed as osteocalcin production compound incubated for 8 hrs measured after 4 days by EIA relative to 1,25(OH)2D32013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Effects of fluorines on nonsecosteroidal vitamin D receptor agonists.
AID730421Agonist activity at human androgen receptor expressed in HEK293 cells assessed as increase in transcriptional activity in presence of 0.3 nM testosterone by luciferase and beta-galactosidase reporter gene assay2013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
Development of silicon-containing bis-phenol derivatives as androgen receptor antagonists: selectivity switching by C/Si exchange.
AID730429Growth inhibition of human LNCAP cells2013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
Development of silicon-containing bis-phenol derivatives as androgen receptor antagonists: selectivity switching by C/Si exchange.
AID1353235Antifibrotic activity against TGFbeta1 stimulated rat LTC-14 cells assessed as inhibition of collagen 1 synthesis at 0.5 uM after 24 hrs by ELISA relative to calcipotriol2018European journal of medicinal chemistry, Feb-25, Volume: 146Design, synthesis and biological evaluation of non-secosteriodal vitamin D receptor ligand bearing double side chain for the treatment of chronic pancreatitis.
AID741579Agonist activity at VDR in human MG-63 cells expressing VDRE assessed as induction of osteocalcin production after 4 days relative to 1,25(OH)2D32013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
A series of nonsecosteroidal vitamin D receptor agonists for osteoporosis therapy.
AID730425Selectivity index, ratio of agonist PC50 for CMX-GAL4 tagged human VDR to antagonist IC50 for human androgen receptor2013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
Development of silicon-containing bis-phenol derivatives as androgen receptor antagonists: selectivity switching by C/Si exchange.
AID730428Induction of monocytic cell differentiation in human HL60 cells2013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
Development of silicon-containing bis-phenol derivatives as androgen receptor antagonists: selectivity switching by C/Si exchange.
AID255706Vitamin D3 agonistic activity as effective dose for HL-60 monocytic cell differentiation2005Bioorganic & medicinal chemistry letters, Oct-01, Volume: 15, Issue:19
Ligands with dual vitamin D3-agonistic and androgen-antagonistic activities.
AID1353237Antifibrotic activity against TGFbeta1 stimulated rat LTC-14 cells assessed as inhibition of alpha-SMA level at 500 nM after 24 hrs by Western blot2018European journal of medicinal chemistry, Feb-25, Volume: 146Design, synthesis and biological evaluation of non-secosteriodal vitamin D receptor ligand bearing double side chain for the treatment of chronic pancreatitis.
AID1585884Inhibition of Hedgehog signaling pathway in VDR-deficient mouse C3H10T1/2 cells assessed as change in CYP24A1 mRNA expression at 1 uM after 24 hrs by q-PCR analysis2019European journal of medicinal chemistry, Jan-15, Volume: 162Synthesis and evaluation of third generation vitamin D3 analogues as inhibitors of Hedgehog signaling.
AID730431Agonist activity at CMX-GAL4 tagged human VDR expressed in HEK293 cells assessed as increase in transcriptional activity by luciferase reporter gene assay2013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
Development of silicon-containing bis-phenol derivatives as androgen receptor antagonists: selectivity switching by C/Si exchange.
AID1353232Inhibition of fluoromone VDR red binding to human VDR LBD expressed in insect cells at 1 uM by fluorescent polarization assay relative to 1,25(OH)2D32018European journal of medicinal chemistry, Feb-25, Volume: 146Design, synthesis and biological evaluation of non-secosteriodal vitamin D receptor ligand bearing double side chain for the treatment of chronic pancreatitis.
AID1585871Activation of VDR in mouse ASZ001 cells assessed as change in Cyp24A1 mRNA expression at 1 uM after 48 hrs by q-PCR analysis relative to control2019European journal of medicinal chemistry, Jan-15, Volume: 162Synthesis and evaluation of third generation vitamin D3 analogues as inhibitors of Hedgehog signaling.
AID1585867Activation of VDR in mouse C3H10T1/2 cells assessed as change in Cyp24A1 mRNA expression at 2.5 uM after 24 hrs by q-PCR analysis relative to control2019European journal of medicinal chemistry, Jan-15, Volume: 162Synthesis and evaluation of third generation vitamin D3 analogues as inhibitors of Hedgehog signaling.
AID741581Agonist activity at VDR in human MG-63 cells expressing VDRE after 3 days by luciferase reporter gene based luminescence assay relative to 1,25(OH)2D32013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
A series of nonsecosteroidal vitamin D receptor agonists for osteoporosis therapy.
AID1353234Transactivation of VDR (unknown origin) expressed in HEK293 cells harboring pENTER-CMV-human RXRalpha at 10'-8M to 10'-6M after 24 hrs by luciferase reporter gene assay2018European journal of medicinal chemistry, Feb-25, Volume: 146Design, synthesis and biological evaluation of non-secosteriodal vitamin D receptor ligand bearing double side chain for the treatment of chronic pancreatitis.
AID1824244Selectivity index, ratio of IC50 for Inhibition of hedgehog signalling in mouse VDR-KO MEF cells to IC50 for inhibition of hedgehog signalling in mouse ASZ001 cells2022European journal of medicinal chemistry, Jan-15, Volume: 228Affinity-based protein profiling identifies vitamin D3 as a heat shock protein 70 antagonist that regulates hedgehog transduction in murine basal cell carcinoma.
AID1353238Antifibrotic activity against TGFbeta1 stimulated rat LTC-14 cells assessed as inhibition of collagen 1 alpha 1 mRNA expression at 500 nM after 24 hrs by RT-qPCR analysis2018European journal of medicinal chemistry, Feb-25, Volume: 146Design, synthesis and biological evaluation of non-secosteriodal vitamin D receptor ligand bearing double side chain for the treatment of chronic pancreatitis.
AID256061Activity ratio of effective dose against vitamin D3 and inhibitory activity against androgen antagonistic activity2005Bioorganic & medicinal chemistry letters, Oct-01, Volume: 15, Issue:19
Ligands with dual vitamin D3-agonistic and androgen-antagonistic activities.
AID255943Androgen antagonistic activity as inhibitory concentration against testosterone-induced SC-3 cell proliferation2005Bioorganic & medicinal chemistry letters, Oct-01, Volume: 15, Issue:19
Ligands with dual vitamin D3-agonistic and androgen-antagonistic activities.
AID1585868Inhibition of Hedgehog signaling pathway in mouse ASZ001 cells assessed as reduction in oxysterol-induced Gli1 mRNA expression after 48 hrs by q-PCR analysis2019European journal of medicinal chemistry, Jan-15, Volume: 162Synthesis and evaluation of third generation vitamin D3 analogues as inhibitors of Hedgehog signaling.
AID730426Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of transcriptional activity at 10 uM by luciferase and beta-galactosidase reporter gene assay2013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
Development of silicon-containing bis-phenol derivatives as androgen receptor antagonists: selectivity switching by C/Si exchange.
AID721296Agonist activity at VDR in human MG-63 cells assessed as transcriptional activation of osteopontin gene after 3 days by luciferase reporter gene assay relative to 1,25(OH)2D32013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Effects of fluorines on nonsecosteroidal vitamin D receptor agonists.
AID670418Agonist activity at VDR expressed in human MG63 cells assessed as stimulation of VDRE-mediated luciferase reporter gene activity after 3 days by luminescence analysis relative to 1,25(OH)2D32012Bioorganic & medicinal chemistry, Jul-15, Volume: 20, Issue:14
Systematic SAR study of the side chain of nonsecosteroidal vitamin D₃ analogs.
AID721294Induction of human HL60 cell differentiation after 4 days by WST-8 assay relative to 1.25-OH2 D32013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Effects of fluorines on nonsecosteroidal vitamin D receptor agonists.
AID1585865Inhibition of Hedgehog signaling pathway in mouse C3H10T1/2 cells assessed as reduction in oxysterol-induced Gli1 mRNA expression after 24 hrs by q-PCR analysis2019European journal of medicinal chemistry, Jan-15, Volume: 162Synthesis and evaluation of third generation vitamin D3 analogues as inhibitors of Hedgehog signaling.
AID1353239Antifibrotic activity against TGFbeta1 stimulated rat LTC-14 cells assessed as inhibition of alpha-SMA mRNA expression at 500 nM after 24 hrs by RT-qPCR analysis2018European journal of medicinal chemistry, Feb-25, Volume: 146Design, synthesis and biological evaluation of non-secosteriodal vitamin D receptor ligand bearing double side chain for the treatment of chronic pancreatitis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's6 (75.00)24.3611
2020's1 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.16

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.16 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index5.35 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (13.16)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]